Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab

被引:18
作者
Llinares-Tello, Francisca [1 ]
Gomez de Salazar, Jose Rosas [2 ]
Senabre Gallego, Jose Miguel [2 ]
Santos Soler, Gregorio [2 ]
Santos Ramirez, Carlos [3 ]
Salas Heredia, Esteban [2 ]
Molina Garcia, Juan [1 ]
机构
[1] Marina Baixa Hosp, Dept Lab, Alicante, Spain
[2] Marina Baixa Hosp, Dept Rheumatol, Alicante, Spain
[3] Marina Salud Hosp, Dept Rheumatol, Alicante, Spain
关键词
RHEUMATOID-ARTHRITIS; ANTIBODIES;
D O I
10.1515/cclm-2012-0050
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:1845 / 1847
页数:3
相关论文
共 10 条
[1]   Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis [J].
Bartelds, Geertje M. ;
Wijbrandts, Carla A. ;
Nurmohamed, Michael T. ;
Stapel, Steven ;
Lems, Willem F. ;
Aarden, Lucien ;
Dijkmans, Ben A. C. ;
Tak, Paul Peter ;
Wolbink, Gerrit Jan .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) :921-926
[2]   Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up [J].
Bartelds, Geertje M. ;
Krieckaert, Charlotte L. M. ;
Nurmohamed, Michael T. ;
van Schouwenburg, Pauline A. ;
Lems, Willem F. ;
Twisk, Jos W. R. ;
Dijkmans, A. C. ;
Aarden, Lucien ;
Wolbink, Gerrit Jan .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (14) :1460-1468
[3]   Venous and Arterial Thromboembolic Events in Adalimumab-Treated Patients With Antiadalimumab Antibodies [J].
Korswagen, L. A. ;
Bartelds, G. M. ;
Krieckaert, C. L. M. ;
Turkstra, F. ;
Nurmohamed, M. T. ;
van Schaardenburg, D. ;
Wijbrandts, C. A. ;
Tak, P. P. ;
Lems, W. F. ;
Dijkmans, B. A. C. ;
van Vugt, R. M. ;
Wolbink, G. J. .
ARTHRITIS AND RHEUMATISM, 2011, 63 (04) :877-883
[4]   Therapeutic Drug Monitoring of Infliximab in Spondyloarthritis: An Observational Open-Label Study [J].
Meric, Jean-Camille ;
Mulleman, Denis ;
Ducourau, Emilie ;
Lauferon, Francine ;
Lin, Delphine Chu Miow ;
Watier, Herve ;
Goupille, Philippe ;
Paintaud, Gilles .
THERAPEUTIC DRUG MONITORING, 2011, 33 (04) :411-416
[5]   Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products [J].
Mire-Sluis, AR ;
Barrett, YC ;
Devanarayan, V ;
Koren, E ;
Liu, H ;
Maia, M ;
Parish, T ;
Scott, G ;
Shankar, G ;
Shores, E ;
Swanson, SJ ;
Taniguchi, G ;
Wierda, D ;
Zuckerman, LA .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 289 (1-2) :1-16
[6]   Trough Infliximab Concentrations Predict Efficacy and Sustained Control of Disease Activity in Rheumatoid Arthritis [J].
Mulleman, Denis ;
Lin, Delphine Chu Miow ;
Ducourau, Emilie ;
Emond, Patrick ;
Ternant, David ;
Magdelaine-Beuzelin, Charlotte ;
Valat, Jean-Pierre ;
Paintaud, Gilles ;
Goupille, Philippe .
THERAPEUTIC DRUG MONITORING, 2010, 32 (02) :232-236
[7]   Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis [J].
Pascual-Salcedo, Dora ;
Plasencia, Chamaida ;
Ramiro, Susana ;
Nuno, Laura ;
Bonilla, Gema ;
Nagore, Daniel ;
Ruiz del Agua, Ainhoa ;
Martinez, Antonio ;
Aarden, Lucien ;
Martin-Mola, Emilio ;
Balsa, Alejandro .
RHEUMATOLOGY, 2011, 50 (08) :1445-1452
[8]   Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis [J].
Radstake, T. R. D. J. ;
Svenson, M. ;
Eijsbouts, A. M. ;
van den Hoogen, F. H. J. ;
Enevold, C. ;
van Riel, P. L. C. M. ;
Bendtzen, K. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (11) :1739-1745
[9]  
ROSAS J, 2011, ARTHRITIS RHEUM S, V63, pS2211
[10]   Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis [J].
Wolbink, GJ ;
Vis, M ;
Lems, W ;
Voskuyl, AE ;
de Groot, E ;
Nurmohamed, MT ;
Stapel, S ;
Tak, PP ;
Aarden, L ;
Dijkmans, B .
ARTHRITIS AND RHEUMATISM, 2006, 54 (03) :711-715